HERON THERAPEUTICS, INC. /DE/ Debt Instrument, Interest Rate, Stated Percentage
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Debt Instrument, Interest Rate, Stated Percentage of 9.95% as of 2023-08-15, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2026-08-10
- 2023-08-15: Debt Instrument, Interest Rate, Stated Percentage 9.95%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2023-08-15 | 9.95% 10-Q · filed 2026-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |